The trademark application nRavel was filed by Indivumed GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 5, 2021, and it was registered by office on July 13, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1662234 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on November 28, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals
Human and animal sample materials, tissue preparations and samples, blood, serum, plasma, urine, stools, test kits in particular comprising diagnostic reagents, diagnostic and therapeutic preparations, in particular made using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods
Biological material collections
Cancer material collections
Medical sample collections
Biological sample collections
Biopsy material collections
All the afore-mentioned in particular with regard to the field of oncology.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto
Industrial analysis and research services
Design and development of computer hardware and software, in particular computer programs
Scientific research for medical purposes, in particular molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy
Typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods for research purposes
Collection of human and animal biospecimen and clinical data
Generation and provision of multi-omics data from human and animal biospecimen, in particular genomic, epigenomic, proteomic, phosphorproteomic, RNA, transcriptomic, lipidomic and metabolomic data
Medical laboratory services, namely, typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods
Database design and development
Hosting databases
Installation, maintenance and updating of database software
Providing scientific research information and results from an online searchable database
Programming of databases
Collecting genetic, medical, biomedical, biologic, chemical and biochemical data and information, in particular information generated through the use of imaging techniques, the use of liquid biopsy methods, the use of histopathological analysis and procedures, the use of genetic analysis and the use of genomics, proteomics, transcriptomics, metabolomics, lipidomics and/or glycomics studies and analysis for medical research
Scientific and laboratory analysis using bioinformatics and/or computational biology, as far as included in this class
All the afore-mentioned in particular with regard to the field of oncology.
The mark was filed in class 44 with following description of goods:
Medical analysis in connection with the treatment of individuals (including X-rays and blood samples) as well as the provision of analysis files and/or software
Medical clinic services
Pharmaceutical advisory services
Medical analysis services using bioinformatics and/or computational biology, as far as included in this class
Providing supporting services and advice to hospitals and other medical care centers in the collection and stabilization of human and animal biospecimen, and the collection of related clinical data
All the afore-mentioned in particular with regard to the field of oncology.